Acute Pyelonephritis in Adults: Prediction of Mortality and Failure of Treatment
Overview
Authors
Affiliations
Background: To formulate a classification tool for early recognition of patients admitted with acute pyelonephritis (AP) who are at high risk for failure of treatment or for death.
Methods: A retrospective chart review of 225 patients (102 men) admitted with AP. We considered 13 potential risk factors in a multivariate analysis.
Results: Recent hospitalization, previous use of antibiotics, and immunosuppression were found to be independent correlates of the prevalence of resistant pathogens in both sexes. Additional predictors included nephrolithiasis in women and a history of recurrent AP in men. Prolonged hospitalization should be expected for a man with diabetes and long-term catheterization who is older than 65 years or for a woman of any age with the same characteristics, when the initial treatment was changed according to the results of urine culture. For mortality prediction, we derived an integer-based scoring system with 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for previous antibiotic treatment for men and 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for immunosuppression for women. Among patients with at least 11 points, the risk for in-hospital death was 100% for men and 91% for women.
Conclusions: Simple variables available at presentation can be used for risk stratification of patients with AP. The additional identification of certain risk factors by means of a carefully obtained history could contribute to early recognition of patients infected by resistant bacteria and optimize the selection of antimicrobial agents.
Nocua-Baez L, Reyes P, Cortes J Antibiotics (Basel). 2025; 14(2).
PMID: 40001440 PMC: 11851720. DOI: 10.3390/antibiotics14020197.
Cortes J, Sierra C, Sanchez R Antibiotics (Basel). 2024; 13(3).
PMID: 38534709 PMC: 10967530. DOI: 10.3390/antibiotics13030274.
Androgen exposure impairs neutrophil maturation and function within the infected kidney.
Hreha T, Collins C, Cole E, Jin R, Hunstad D mBio. 2024; 15(2):e0317023.
PMID: 38206009 PMC: 10865792. DOI: 10.1128/mbio.03170-23.
Zabkowski T, Durma A, Grabinska A, Michalczyk L, Saracyn M J Clin Med. 2023; 12(12).
PMID: 37373574 PMC: 10299108. DOI: 10.3390/jcm12123879.
Can Urinalysis and Past Medical History of Kidney Stones Predict Urine Antibiotic Resistance?.
Mohseni M, Craver E, Heckman M, Sheele J West J Emerg Med. 2022; 23(5):613-617.
PMID: 36205684 PMC: 9541996. DOI: 10.5811/westjem.2022.4.54872.